Welcome to Critical MassLaw.com’s weekly briefing for class action and mass tort attorneys. Jury selection begins today in a closely watched opioid trial, despite several last-ditch efforts to avoid it. An $8 billion Risperdal verdict notwithstanding, Johnson & Johnson is having a really good month in talcum powder cases. Find out who’s repping DSW Shoe Warehouse in a closet full of TCPA class actions.

Feel free to reach out to me with your input. You can email me at [email protected], or follow me on Twitter@abronstadlaw

An October Surprise for the Opioid Trial?